235 related articles for article (PubMed ID: 26377541)
1. Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells.
Khan MI; Czarnecka AM; Helbrecht I; Bartnik E; Lian F; Szczylik C
Stem Cell Res Ther; 2015 Sep; 6(1):178. PubMed ID: 26377541
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry in cancer stem cell analysis and separation.
Greve B; Kelsch R; Spaniol K; Eich HT; Götte M
Cytometry A; 2012 Apr; 81(4):284-93. PubMed ID: 22311742
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Cancer Stem Cells.
Orecchioni S; Bertolini F
Methods Mol Biol; 2016; 1464():49-62. PubMed ID: 27858355
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of cancer stem cells in renal cell carcinoma.
Lucarelli G; Galleggiante V; Rutigliano M; Vavallo A; Ditonno P; Battaglia M
Urologia; 2015; 82(1):46-53. PubMed ID: 25451878
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Qureshi-Baig K; Ullmann P; Haan S; Letellier E
Mol Cancer; 2017 Feb; 16(1):40. PubMed ID: 28209178
[TBL] [Abstract][Full Text] [Related]
7. Methods for cancer stem cell detection and isolation.
Tirino V; Desiderio V; Paino F; Papaccio G; De Rosa M
Methods Mol Biol; 2012; 879():513-29. PubMed ID: 22610581
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
9. Isolation and culture of colon cancer stem cells.
Cammareri P; Lombardo Y; Francipane MG; Bonventre S; Todaro M; Stassi G
Methods Cell Biol; 2008; 86():311-24. PubMed ID: 18442654
[TBL] [Abstract][Full Text] [Related]
10. In vitro enrichment of tumor-initiating cells from human established cell lines.
Benayoun L; Shaked Y
Curr Protoc Stem Cell Biol; 2013 Feb; Chapter 3():Unit 3.7. PubMed ID: 23404675
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
[TBL] [Abstract][Full Text] [Related]
12. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
[TBL] [Abstract][Full Text] [Related]
13. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
[TBL] [Abstract][Full Text] [Related]
14. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
15. Immunology of cancer stem cells in solid tumours. A review.
Maccalli C; Volontè A; Cimminiello C; Parmiani G
Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
[TBL] [Abstract][Full Text] [Related]
16. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: potent targets for cancer stem cell therapy.
Torigoe T; Hirohashi Y; Yasuda K; Sato N
Int J Hyperthermia; 2013 Aug; 29(5):436-41. PubMed ID: 23902339
[TBL] [Abstract][Full Text] [Related]
19. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
20. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
